LYDIA PICOTTE: Open Payments
NPI 1063192383 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 20 payments from 12 companies in 2025. Trend: 2023 $146 · 2024 $280 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $47 |
| ABBVIE INC. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $38 |
| Amgen Inc. | 2 | $38 |
| Exact Sciences Corporation | 2 | $36 |
| Antares Pharma, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $22 |
| PFIZER INC. | 1 | $15 |
Products named: Veozah, OTEZLA, REXULTI, The Cologuard Plus Collection Kit, XYOSTED, MOUNJARO, Wegovy, KEVEYIS.
Industry payments across OR — which companies pay providers there.
